Irish Medical Technology Company Aerogen announces 20 new jobs for 2016

For the second time in three years, Aerogen, the Irish global leader in aerosol drug delivery, has received the prestigious 2015 Zenith Award for respiratory care excellence from the American Association of Respiratory Care (AARC) at the annual AARC Congress in Tampa, Florida.

Widely recognized as the “People’s Choice” award of the respiratory care profession, the Zenith Award was voted on by over 52,000 respiratory therapists and allied health practitioners.  Aerogen was one of just six companies chosen from more than 400 eligible suppliers to receive the award, which was conferred in recognition of the impact of its breakthrough vibrating mesh technology on the respiratory care profession, as well as its commitment to service excellence and truth in advertising.

The award comes as Aerogen, which employs over 100 people in Ireland, reported 2015 business growth of 30% and filled 17 new full-time positions in the State.  On the back of two new product launches in 2015 the company plans further expansion of its Irish operations next year to reinforce its market leadership in acute care aerosol drug delivery, with similar growth in job numbers anticipated.  New roles will be created across company functions in areas such as Design, Marketing, Quality and Regulatory Affairs, reinforcing Aerogen’s commitment to innovation and excellence in respiratory care.

Aerogen’s patented palladium vibrating mesh technology lies at the heart of its category-leading aerosol drug delivery systems, which are used by over 80% of the hospitals in Ireland and over 1000 hospitals in the US to deliver aerosol medication in the acute care setting.

This proprietary technology turns liquid medication into a fine particle mist, gently and effectively delivering drugs to the lungs of critically ill patients.  Innovative products such as the Aerogen Solo offer improved patient care and less drug wastage, while also significantly reducing patient treatment times, length of stay and related hospital care costs.

Commenting on the accolade, which Aerogen also received in 2013, John Power, Aerogen CEO, said: “We are honored to once again receive the 2015 Zenith Award and delighted to be held in such high regard by respiratory care therapists and healthcare practitioners who work every day to improve patients’ lives.  I must also pay tribute to our great team and the support they offer our valued customers.

“Aerogen strives for excellence in everything we do. We work hand in hand with respiratory care professionals at all levels and I wish to thank them not only for this award, but for their continued support to deliver the best possible patient care.”